Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ileana De Roma"'
Autor:
Maria Colomba Comes, Livia Fucci, Sabino Strippoli, Samantha Bove, Gerardo Cazzato, Carmen Colangiuli, Ivana De Risi, Ileana De Roma, Annarita Fanizzi, Fabio Mele, Maurizio Ressa, Concetta Saponaro, Clara Soranno, Rosita Tinelli, Michele Guida, Alfredo Zito, Raffaella Massafra
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background Risk stratification and treatment benefit prediction models are urgent to improve negative sentinel lymph node (SLN-) melanoma patient selection, thus avoiding costly and toxic treatments in patients at low risk of recurrence. To
Externí odkaz:
https://doaj.org/article/95ad4c7525344afab6eec62c16a1a0f7
Autor:
Teresa Squicciarini, Rossella Villani, Benedetta Apollonio, Livia Fucci, Milena Zambetti, Michele Rossini, Rosamaria Pinto, Stefania Tommasi, Ileana De Roma, Sabino Strippoli, Michele Guida
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundDesmoplastic melanoma (DM) is a rare subtype of melanoma characterized by high immunogenicity which makes it particularly suitable for immune checkpoint inhibitors (ICIs) treatment.Case presentationWe report the case of a 53-year-old man wi
Externí odkaz:
https://doaj.org/article/c9c8bb77549648988e22b7388167e131
Autor:
Arianna Gadaleta-Caldarola, Laura Lanotte, Stefania Infusino, Ileana De Roma, Antonio Doronzo, Lucia Lombardi, Gennaro Gadaleta-Caldarola, Rosanna Nenna
Publikováno v:
Future oncology (London, England). 17(8)
Metaplastic breast cancer (MPBC) is a rare and aggressive tumor type in great need of satisfactory therapies. Although most cases of MPBC are ‘triple negative’, they are nonetheless related to worse outcomes compared with other triple-negative in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efcb762a1d9be1aed1d12bb82e2b440c
https://pubmed.ncbi.nlm.nih.gov/33538176
https://pubmed.ncbi.nlm.nih.gov/33538176
Publikováno v:
Imaging Gliomas After Treatment ISBN: 9783030312091
The incidence of primary malignant brain tumors has been increasing over the past 30 years, and it is estimated that in the year 2010, approximately 22,020 cases were diagnosed in the USA alone, with 13,140 deaths [1, 2]. Gliomas account for 32% of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20371a83b87ced1bcb4a730fe05677d7
https://doi.org/10.1007/978-3-030-31210-7_4
https://doi.org/10.1007/978-3-030-31210-7_4
